Evotec SE (EVO) Financials: Revenue & Earnings
EVO$1.56-0.04 -2.49%
$555.86M
Market Cap
—
P/E
—
Forward P/E
—
Score
Evotec SE (EVO) Financials: Revenue & Earnings
EVO price $1.56 -0.04 -2.49%
- Ticker
- EVO
- Price
- $1.56
- Change
- -0.04 -2.49%
- Market cap ?
- $555.86M
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
Evotec SE operates globally as a dedicated partner, specializing in the discovery and advancement of new pharmaceutical products for the biotechnology and pharmaceutical sectors. Its comprehensive research and development initiatives encompass a broad spectrum of medical areas, such as metabolic disorders (including diabetes and its complications), fibrosis, infectious conditions, central nervous system (CNS)…
Earnings and financials
Evotec SE (EVO) trades at $1.56, with a market cap of $555.86M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn